Neuromedin B receptor antagonists which demonstrate selectivity

Details Neuromedin B receptor antagonists which demonstrate selectivity Neuromedin B receptor antagonists which demonstrate selectivity

1993-06-17

1995-10-31

Warden, Jill

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

530311, 530328, A61K 3800, C07K 500, C07K 700, C07K 1700

Patent

active

054629268

ABSTRACT:
A method of selectively inhibiting biochemical activity of cells induced by neuromedin B. The method includes the step of contacting cells which contain neuromedin B receptor with a cyclic octapeptide, D-Nal-Cys-Tyr-D-Trp-Lys-Val-Cys-Nal-NH.sub.2, or an analog thereof.

REFERENCES:
patent: 5003011 (1991-03-01), Coy et al.

Affiliated with

Also associated with

Rating

Neuromedin B receptor antagonists which demonstrate selectivity does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Neuromedin B receptor antagonists which demonstrate selectivity, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Neuromedin B receptor antagonists which demonstrate selectivity will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1772304